House Bill No. 350 amends the Health and Safety Code to establish guidelines for the use of glucagon medication in public and private schools. The bill defines "glucagon medication" as any medication used to treat hypoglycemia that contains glucagon and clarifies the definitions of "school" and "school employee." It allows school districts, open-enrollment charter schools, and private schools to adopt policies regarding the maintenance, administration, and disposal of glucagon medication on their campuses. The policies must ensure that a school nurse or an unlicensed diabetes care assistant can administer glucagon to students believed to be experiencing hypoglycemia, provided that a diabetes management and treatment plan has been submitted for the student.

Additionally, the bill outlines that schools are not required to purchase glucagon medication or incur any expenses that would negatively impact their finances. It also allows for the prescription of glucagon medication in the name of the school by a physician or authorized person, and establishes that a standing order for administration does not need to be patient-specific. The provisions of this act will take effect starting with the 2025-2026 school year, and it will become effective immediately if it receives a two-thirds vote from both houses of the legislature.

Statutes affected:
Introduced: Health and Safety Code 168.001 (Health and Safety Code 168)